Alykhan Motani
- Molecular Biology top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Surgery top 10%
- Cancer Research top 10%
- Immunology top 10%
- Co-authors
- Gordon A. FernsElaine W. RainesM A ReidyK. H. SprugelErik ÄnggårdG. FernsQingxiang LiuMarc de Gasparo
- Topics
- Growth Hormone and Insulin-like Growth Factors (4 papers)Platelet Disorders and Treatments (2 papers)Retinal Diseases and Treatments (2 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Alykhan Motani
17 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Molecular Biology 764
- Cardiology and Cardiovascular Medicine 295
- Surgery 293
- Cancer Research 218
- Immunology 217
Countries citing papers authored by Alykhan Motani
This map shows the geographic impact of Alykhan Motani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alykhan Motani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alykhan Motani more than expected).
Fields of papers citing papers by Alykhan Motani
This network shows the impact of papers produced by Alykhan Motani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alykhan Motani. The network helps show where Alykhan Motani may publish in the future.
Co-authorship network of co-authors of Alykhan Motani
This figure shows the co-authorship network connecting the top 25 collaborators of Alykhan Motani. A scholar is included among the top collaborators of Alykhan Motani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alykhan Motani. Alykhan Motani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 6 | |
| 3 | 1 | |
| 4 | 14 | |
| 5 | 9 | |
| 6 | 14 | |
| 7 | 18 | |
| 8 | 45 | |
| 9 | 68 | |
| 10 | 98 | |
| 11 | 79 | |
| 12 | 0 | |
| 13 | 18 | |
| 14 | 19 | |
| 15 | 18 | |
| 16 | Inhibition of Neointimal Smooth Muscle Accumulation After Angioplasty by an Antibody to PDGFbreakdown → | 933 |
| 17 | The insulin-like growth factors: their putative role in atherogenesis. | 50 |
| 18 | 84 |
About Alykhan Motani
Alykhan Motani is a scholar working on Endocrinology, Diabetes and Metabolism, Endocrine and Autonomic Systems and Ophthalmology, having authored 18 papers that have together received 1.5k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (4 papers), Platelet Disorders and Treatments (2 papers) and Retinal Diseases and Treatments (2 papers). The work is most often cited by research in Immunology and Allergy (188 citations), Cancer Research (218 citations) and Cardiology and Cardiovascular Medicine (295 citations). Alykhan Motani has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Gordon A. Ferns, Elaine W. Raines, M A Reidy, K. H. Sprugel, Erik Änggård, G. Ferns, Qingxiang Liu, Marc de Gasparo, B. Kamber and Steven Whitebread. Their work appears in journals such as Science, Journal of Biological Chemistry and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.